MELD Na (UNOS/OPTN)
ورودیهای بالینی بیمار
حداقل ۰.۰۱ — حداکثر ۴۰ • واحد: mg/dL
حداقل ۰.۰۱ — حداکثر ۱۰۰ • واحد: mg/dL
حداقل ۰.۰۱ — حداکثر ۱۰۰
حداقل ۱۰۰ — حداکثر ۱۵۰ • واحد: mEq/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk6–9
- Moderate Risk10–19
- High Risk20–29
- Very High Risk30–39
Clinical Decision Pathway
Clinical Decision Pathway & Next Steps
Hepatology, Alcoholic Hepatitis & GI Bleeding — بیماریهای کبدی، هپاتیت الکلی و خونریزی گوارشی
Clinical Rationale:
Assess chronic liver failure with Child-Pugh, MELD, and MELD-Na; evaluate alcoholic hepatitis severity with Maddrey and GAHS for steroid indication, and triage upper GI bleeding with Glasgow-Blatchford and AIMS65.
MELD Score (Original, Pre-2016, Model for End-Stage Liver Disease)
امتیاز MELD کلاسیک
Recommended Clinical Next Steps:
Maddrey's Discriminant Function for Alcoholic Hepatitis
تابع مادری برای هپاتیت الکلی
Why next: Corticosteroid indication in alcoholic hepatitisGlasgow Alcoholic Hepatitis Score (GAHS)
امتیاز هپاتیت الکلی گلاسکو (GAHS)
Why next: Predict survival response to corticosteroid therapyGlasgow-Blatchford Bleeding Score (GBS)
امتیاز خونریزی گلاسکو-بلاچفورد (GBS)
Why next: Pre-endoscopy triage for outpatient safety
The MELD Na (UNOS/OPTN) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include creatinine. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Quantifies end-stage liver disease for transplant planning with sodium, used by UNOS for liver allocation since 2016
Clinical Indication
The MELD Na (UNOS/OPTN) is indicated for bedside clinical practice to support Quantifies end-stage liver disease for transplant planning with sodium, used by UNOS for liver allocation since 2016. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.
MELD(i) = 0.957 × ln(Cr) + 0.378 × ln(bilirubin) + 1.120 × ln(INR) + 0.643, then if MELD(i) > 11: MELD Na = MELD(i) + 1.32 × (137 - Na) - [0.033 × MELD(i) × (137 - Na)]
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| creatinine | float | Yes | Serum creatinine in mg/dL. If patient on dialysis ≥2 times in past week, use 4.0. If <1.0, use 1.0(mg/dL) |
| bilirubin | float | Yes | Total bilirubin in mg/dL. If <1.0, use 1.0(mg/dL) |
| inr | float | Yes | International Normalized Ratio (INR). If <1.0, use 1.0 |
| sodium | float | Yes | Serum sodium in mEq/L. Values <125 are set to 125, values >137 are set to 137(mEq/L) |
| dialysis_twice_past_week | string | Yes | Has the patient had dialysis (hemodialysis, peritoneal dialysis, CVVHD) at least twice in the past week? |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 6–9 | Low Risk | MELD Na ≤9 |
| 10–19 | Moderate Risk | MELD Na 10-19 |
| 20–29 | High Risk | MELD Na 20-29 |
| 30–39 | Very High Risk | MELD Na 30-39 |
| 40–40 | Extremely High Risk | MELD Na ≥40 |
Evidence-Based References (EBM)
- Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008 Sep 4;359(10):1018-26. doi: 10.1056/NEJMoa0801209.DOI: 10.1056/NEJMoa0801209
- Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007 Mar;45(3):797-805. doi: 10.1002/hep.21563.DOI: 10.1002/hep.21563
- OPTN Policy 9: Allocation of Livers and Liver-Intestines. Organ Procurement and Transplantation Network. Effective January 11, 2016.